Estimation of outpatient SARS-CoV-2 reinfection and recurrence rates and associated factors among COVID-19 hospitalized patients over one-year old: a multicenter retrospective cohort study

被引:1
|
作者
Mokhayeri, Yaser [1 ]
Taherpour, Niloufar [2 ]
Shahbazi, Fatemeh [3 ]
Ghorbani, Sahar Sotoodeh [4 ]
Fallah, Saeid [5 ]
Etemad, Koorosh [4 ]
Izadi, Neda [6 ]
Mehri, Ahmad [4 ]
Farhadi-Babadi, Kosar [4 ]
Rahimi, Elham [4 ]
Feyzi, Rezvan [4 ]
Seifi, Arash [7 ]
Nazari, Seyed Saeed Hashemi [8 ]
机构
[1] Lorestan Univ Med Sci, Shahid Rahimi Hosp, Cardiovasc Res Ctr, Khorramabad, Iran
[2] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Tehran, Iran
[3] Hamadan Univ Med Sci Hamadan, Sch Hlth, Dept Epidemiol, Hamadan, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[5] Golestan Univ Med Sci, Hlth Management & Social Dev Res Ctr, Gorgan, Iran
[6] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran
[7] Univ Tehran Med Sci, Fac Med, Dept Infect Dis, Tehran, Iran
[8] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Sch Publ Hlth & Safety, Dept Epidemiol, Daneshjoo Blvd,Evin Ave, Tehran 1983535511, Iran
关键词
SARS-Cov-2; Reinfection; Recurrence; Out-patient; Iran; RISK-FACTORS; INFECTION;
D O I
10.1186/s12879-024-09872-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionReinfection with SARS-Cov-2 after recovery can occur that most of them don't require hospitalization. The aim of this study is estimation of out-patient COVID-19 reinfection and recurrence rates and its associated factors among Iranian patients with history of confirmed SARS-Cov-2 infection and hospitalization.MethodsThis study is a retrospective cohort conducted from May 2021 to May 2022 in Iran. The national Medical Care Monitoring Center (MCMC) database, obtained from the Ministry of Health and Medical Education, includes all information about confirmed COVID-19 patients who are hospitalized and diagnosed during the pandemic. Using probability proportional to size sampling from 31 provinces, 1,532 patients over one years of age with a history of hospitalization in the MCMC data are randomly selected. After that, interviews by phone are performed with all of the selected patients using a researcher-made questionnaire about the occurrence of overall reinfection without considering the time of infection occurrence, reinfection occurring at least 90 days after the discharge and recurrence (occurring within 90 days after discharge). Univariate and multivariable Cox regression analyses are performed to assess the factors associated with each index. All of the analyses are performed using Stata software version 16.ResultsIn general, 1,532 phone calls are made, out of which 1,095 individuals are willing to participate in the study (response rate similar or equal to 71%). After assessing the 1,095 patients with a positive history of COVID-19, the rates of non-hospitalized overall SARS-Cov-2 reinfection, reinfection and recurrence are 122.64, 114.09, and 8.55 per 1,000 person-years, respectively. The age range of 19-64 years (aHR:3.93, 95%CI : 1.24-12.41) and COVID-19-related healthcare worker (aHR: 3.67, 95%CI: 1.77-7.61) are identified as risk factors for reinfection, while having comorbidity, being fully vaccinated, and having a partial pressure of oxygen (PaO2) >= 93 mmHg during the initial infection are identified as factors that reduce the risk of non-hospitalized reinfection.ConclusionReinfection due to COVID-19 is possible because of the weakened immune system for various reasons and the mutation of the virus. Vaccination, timely boosters, and adherence to preventive measures can help mitigate this risk.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study
    Taherpour, Niloufar
    Etemad, Koorosh
    Mokhayeri, Yaser
    Fallah, Saeid
    Ghorbani, Sahar Sotoodeh
    Izadi, Neda
    Rahimi, Elham
    Shahbazi, Fatemeh
    Seifi, Arash
    Mehri, Ahmad
    Feyzi, Rezvan
    Farhadi-Babadi, Kosar
    Nazari, Seyed Saeed Hashemi
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2024, 12 (01)
  • [2] Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
    Slezak, Jeff
    Bruxvoort, Katia
    Fischer, Heidi
    Broder, Benjamin
    Ackerson, Bradley
    Tartof, Sara
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1860.e7 - 1860.e10
  • [3] Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective
    Miao, Miao
    Clercq, Erik De
    Li, Guangdi
    BIOMEDICINES, 2021, 9 (04)
  • [4] Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study
    Lu, Yun
    Yang, Qing-qing
    Zhuo, Lin
    Yang, Kun
    Kou, Hao
    Gao, Su-yu
    Hu, Wen
    Jiang, Qiao-li
    Li, Wen-jing
    Wu, Dong-fang
    Sun, Feng
    Cheng, Hong
    Zhan, Siyan
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [5] Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study
    Mo, Pingzheng
    Deng, Liping
    Liu, Xiaoping
    Gao, Shicheng
    Liang, Ke
    Luo, Mingqi
    Chen, Tielong
    Song, Shihui
    Ma, Zhiyong
    Chen, Xiaoping
    Fan, Junli
    Wang, Fan
    Xiong, Yong
    Zhang, Yongxi
    EPIDEMIOLOGY & INFECTION, 2020, 148
  • [6] Rate, risk factors, and clinical outcomes of SARS-CoV-2 reinfection vs. primary infection in readmitted COVID-19 patients in Iran: a retrospective cohort study
    Shahrbaf, Mohammadamin
    Alimohamadi, Yousef
    Arfaei, Reza Yousefi
    Salesi, Mahmood
    Izadi, Morteza
    Raei, Mehdi
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [7] Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
    Nordstrom, Peter
    Ballin, Marcel
    Nordstrom, Anna
    LANCET INFECTIOUS DISEASES, 2022, 22 (06) : 781 - 790
  • [8] Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study
    Hesni, Ezat
    Sayad, Babak
    Shadmani, Fatemeh Khosravi
    Najafi, Farid
    Khodarahmi, Reza
    Rahimi, Zohreh
    Bozorgomid, Arezoo
    Sayad, Nazanin
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [9] Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study
    Ezat Hesni
    Babak Sayad
    Fatemeh Khosravi Shadmani
    Farid Najafi
    Reza Khodarahmi
    Zohreh Rahimi
    Arezoo Bozorgomid
    Nazanin Sayad
    BMC Infectious Diseases, 22
  • [10] Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
    He, Xin-liang
    Zhou, Ya-ya
    Fu, Wei
    Xue, Yu-e
    Liang, Meng-yuan
    Yang, Bo-han
    Ma, Wan-li
    Zhou, Qiong
    Chen, Long
    Zhang, Jian-chu
    Wang, Xiao-rong
    CURRENT MEDICAL SCIENCE, 2021, 41 (06) : 1096 - 1104